Clinical Trial Update: TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial updating trametinib in patients with BRAFV600 wild-type advanced pretreated melanoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Trametinib (trametinib)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Stage IV Melanoma, Stage III Melanoma | Phase 2 | Status: COMPLETED